Comments on the Hammersmith policy

Tim Hughes

doi:10.1053/shem.2003.50056

2003-04-01

PRE

Tim Hughes

DOI：10.1053/shem.2003.50056

原文链接

原文求助

摘要

Keyword:

CHRONIC MYELOID-LEUKEMIA

IMATINIB STI571

CHRONIC PHASE

RESISTANCE

AI总结

对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Seminars in Hematology

IF:

4.1

论文数:

1.4K

被引数:

2.4K

机构

暂无机构信息

引用论文

Are supplementary services provided during methadone maintenance really cost-effective?

American Journal of Psychiatry

IF0

1997-09-01

OAAI

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

LANCET

IF88.5

1998-10-01

540

PREAI

Gratwohl, A; Hermans, J; Goldman, JM; Arcese, W; Carreras, E; Devergie, A; Frassoni, F; Gahrton, G; Kolb, H; Niederwieser, D; Ruutu, T; Vernant, JP; de Witte, T; Apperley, J

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2003-03-13

3.0K

OAAI

O'Brien, SG; Guilhot, F; Larson, RA; Gathmann, I; Baccarani, M; Cervantes, F; Cornelissen, JJ; Fischer, T; Hochhaus, A; Hughes, T; Lechner, K; Nielsen, JL; Rousselot, P; Reiffers, J; Saglio, G; Shepherd, J; Simonsson, B; Gratwohl, A; Goldman, JM; Kantarjian, H; Taylor, K; Verhoef, G; Bolton, AE; Capdeville, R; Druker, BJ; Durrant, S; Schwarer, A; Joske, D; Seymour, J; Grigg, A; Ma, D; Arthur, C; Bradstock, K; Joshua, D; Louwagie, A; Martiat, P; Straetmans, N; Bosly, A; Shustik, C; Lipton, J; Forrest, D; Walker, I; Roy, DC; Rubinger, M; Bence-Bruckler, I; Kovacs, M; Turner, AR; Birgens, H; Bjerrum, O; Facon, T; Harousseau, JL; Tulliez, M; Guerci, A; Blaise, D; Maloisel, F; Michallet, M; Hossfeld, D; Mertelsmann, R; Andreesen, R; Nerl, C; Freund, M; Gattermann, N; Hoeffken, K; Ehninger, G; Deininger, M; Ottmann, O; Peschel, C; Fruehauf, S; Neubauer, A; Le Coutre, P; Aulitzky, W; Fanin, R; Rosti, G; Mandelli, F; Morra, E; Carella, A; Lazzarino, M; Petrini, M; Ferrini, PR; Nobile, F; Liso, V; Ferrara, F; Rizzoli, V; Fioritoni, G; Martinelli, G; Ossenkoppele, G; Browett, P; Gedde-Dahl, T; Tangen, JM; Dahl, I; Odriozola, J; Boluda, JCH; Steegmann, JL; Cañizo, C; Sureda, A; Diaz, J; Granena, A; Fernández, MN; Stenke, L; Paul, C; Bjoreman, M; Malm, C; Wadenvik, H; Nilsson, PG; Turesson, I; Hess, U; Solenthaler, M; Russel, N; Mufti, G; Cavenagh, J; Clark, RE; Green, AR; Holyoake, TL; Lucas, GS; Smith, G; Milligan, DW; Rule, SJ; Burnett, AK; Moroose, R; Wetzler, M; Bearden, J; Brown, R; Lobell, M; Cataland, S; Rabinowitz, I; Meisenberg, B; Gabrilove, J; Thompson, K; Graziano, S; Emanuel, P; Gross, H; Cobb, P; Bhatia, R; Dakhil, S; Irwin, D; Issell, B; Pavletic, S; Kuebler, P; Layhe, E; Butera, P; Glass, J; Moore, J; Grant, B; Niell, H; Herzig, R; Burris, H; Peterson, B; Powell, B; Kalaycio, M; Stirewalt, D; Samlowski, W; Berman, E; Limentani, S; Seay, T; Shea, T; Akard, L; Smith, G; Becker, P; DeVine, S; Hart, R; Veith, R; Wade, J; Brunvand, M; Silver, R; Kalman, L; Strickland, D; Shurafa, M; Bashey, A; Shadduck, R; Cooper, S; Safah, H; Rubenstein, M; Collins, R; Keller, A; Stone, R; Tallman, M; Stevens, D; Pecora, A; Agha, M; Holmes, H; Druker, BJ; Guilhot, F; Larson, RA; O'Brien, SG; Rowe, J; Schiffer, CA; Buyse, M; Baccarani, M; Cervantes, F; Cornelissen, J; Fischer, T; Hochhaus, A; Hughes, T; Kantarjian, H; Lechner, K; Nielsen, JL; Reiffers, J; Rousselot, P; Saglio, G; Shepherd, J; Simonsson, B; Gratwohl, A; Goldman, JM; Taylor, K; Verhoef, G

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α Bcr-abl mRNA转录水平的早期降低可预测干扰素 α 失败后接受伊马替尼治疗的慢性期CML患者的细胞遗传学反应

LEUKEMIA

IF13.4

2002-08-30

147

PREAI

Merx, K; Müller, MC; Kreil, S; Lahaye, T; Paschka, P; Schoch, C; Weisser, A; Kuhn, C; Berger, U; Gschaidmeier, H; Hehlmann, R; Hochhaus, A

Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption

The Journal of Pediatrics

IF0

1982-06-01

PREAI